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ABSTRACT 
Objectives: Study aimed for the simultaneous estimation of Famotidine and Rabeprazole sodium at 263 nm, λmax of Famotidine and 284 nm, λmax
Methods: Method development and validation were done by UV spectrophotometric method. 
 of 
Rabeprazole sodium.  
Results: The method developed obeyed Beer-Lambert’s law in the concentration range of 5-30 µg/ml for both famotidine and rabeprazole. The 
results of the analysis have been successfully validated statistically. The %RSD confirms the precision of the proposed method and Recovery studies 
show the accuracy of the method.  
Conclusion: This method was simple, precise and accurate and was successfully applied to the determination of these drugs in the laboratory 
mixture. 
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INTRODUCTION 
Famotidine chemically 3-[[[2-[(Aminoiminomethyl) amino]-4-
thiazolyl]methyl]thio]-N-(aminosulfonyl) propanimidamide is used 
in the treatment of gastric ulcer, stress ulcer and gastritis [1]. An 
extensive literature survey revealed titrimetry, HPLC, HPTLC and 
Spectrophotometric methods for the analysis of Famotidine in bulk 
and in formulations [2]. 
Rabeprazole sodium is a potent proton pump inhibitor that 
suppresses gastric acid secretion. It is used in the treatment of 
gastrooesophagial reflux disorder (GERD) and duodenal ulcer [3]. 
Chemically Rabeprazole is 2-({[4-(3-methoxypropoxy)-3-
methylpyridin-2-yl] methane} sulfinyl)-1H-1,3 benzodiazole.  
 
 
Fig. 1: Structure of 
Famotidine 
 
Fig. 2: Structure of Rabeprazole 
 
Literature Survey reveals that UV spectrophotometry and RP-HPLC 
methods have been developed for Rabeprazole in single and 
combined dosage forms [4]. 
Studies suggest proton pump inhibitors may not control the gastric 
acidity effectively during the night, especially in gastroesophageal 
reflux disease. It has therefore been suggested that H2
MATERIALS AND METHODS 
 receptor 
blockers should be added to the therapy [5]. However, no methods 
are yet reported for simultaneous estimation of Famotidine and 
Rabeprazole by simple spectrophotometric method. Hence the main 
purpose of the study was to develop a simple, accurate, 
reproducible, rapid and economical method for simultaneous 
estimation of Famotidine and Rabeprazole sodium in bulk and 
validating of method as per ICH norm. 
Drug  
Famotidine was supplied by Zydus Cadilla and Rabeprazole sodium 
was supplied by Dr. Reddy’s Laboratories, Hyderabad. 
Reagents and chemicals 
All other reagents were of analytical grade for Spectrophotometric 
method. 
Instruments  
Jasco V-630 UV spectrophotometer 
Estimation of Famotidine and Rabeprazole by UV-Visible 
spectroscopy 
Preparation of simulated gastric fluid pH 1.2 
Accurately weighed 3.75 g of Potassium chloride was dissolved in 
distilled water and 3.71 ml of Conc. Hydrochloric acid was added to 
it. The final volume was made upto 1000 ml with distilled water. 
Famotidine and Rabeprazole stock solution 
An accurately weighed quantity of Famotidine equivalent to 100 mg 
was dissolved in 100 ml of simulated gastric fluid in 100 ml 
volumetric flask to get 1000 μg/ml. Similarly Rabeprazole equivalent 
to 100 mg was dissolved in 100 ml of simulated gastric fluid in 100 
ml volumetric flask to obtain 1000μg/ml.  
Study of spectra and selection of wavelength 
Aliquot portions of stock solutions of Famotidine and Rabeprazole 
were diluted appropriately with simulated gastric fluid pH 1.2 to 
obtain concentration 10 μg/ml of each drug. The solutions were 
scanned in the range of 400-200 nm in 1 cm cell against blank.  
The UV absorbance spectrum of Famotidine and Rabeprazole is 
shown in fig. 3 and fig. 4. From the spectrum the wavelengths 
selected for estimation of drugs were 263 nm as λmax of Famotidine 
and 284 nm as λmax
Study of beer-lambert’s law 
 of Rabeprazole. 
Aliquots of the working stock solution of Famotidine and 
Rabeprazole were prepared with simulated gastric fluid of pH 1.2 to 
get concentrations in the range of 5-30 µg/ml for Famotidine and 
Rabeprazole. The absorbances of the resulting solutions were 
measured at their respective λmax. A calibration curve as 
concentrations. Absorbance was constructed to study the Beer-
Lambert’s Law and regression equation. 
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Vierodt’s simultaneous equation method 
If a sample contains two absorbing drugs each of which absorbs at 
the λmax of the other, it may be possible to determine both drugs by 
the technique of simultaneous equation method. This method 
analysis is based on the absorption of drugs at the wavelength 
maximum of the order. Quantification analysis of Drug1 and Drug2 
in a binary mixture was performed with the simultaneous equation. 
Analysis of laboratory mixture by proposed method 
In order to see the feasibility of the proposed method for 
simultaneous estimation Famotidine and Rabeprazole in 
pharmaceutical formulations, the method was first tried for the 
estimation of the drugs in standard laboratory mixture. 
Accurately weighed quantities of Famotidine and Rabeprazole 
sodium 100 mg taken in 100 ml volumetric flask and dissolved in 
simulated gastric fluid of pH 1.2 by vigorous shaking. The suitable 
dilution was made to get a final concentration of about 10 μg/ml 
famotidine and 10 μg/ml rabeprazole. The absorbances of the 
resulting solutions were measured at 263 nm and 284 nm in 1 cm 
cell against a blank. Amount of each drug was determined using 
simultaneous equation as following:  
CX =  
A1ay2  −  A2ay1
ax1ay2 −  ax2ay1
 … … … … … (Equ. 1) 
Cy =  
A2ax1 − A1ax2
ax1ay2  − ax2ay1
 … … … … … (Equ. 2) 
Where, 
A1 and A2 are absorbance of Sample solution of Drug1 and Drug2 
respectively.  
ax1 = Absorptivity of Drug1 at A1 nm  
ax2 = Absorptivity of Drug 1 at A2 nm  
ay1 = Absorptivity of Drug 2 at A1 nm  
ay2 
It was determined by measuring the absorbance of various 
concentrations of both drugs Famotidine and Rabeprazole at their 
own respective λ
= Absorptivity of Drug 2 at A2 nm  
Validation of proposed method 
Validation of an analytical method is the process to establish that the 
performance characteristics of the developed method meet the 
requirements of the intended analytical application. The UV method 
was validated in terms of accuracy, precision, LOD, LOQ, linearity 
and sensitivity. 
Linearity 
max and at the λmax
Accuracy 
 of other drug. The response was 
plotted against concentration of the analyte. Linearity of the 
calibration curve was demonstrated by applying the least square 
regression analysis to the plot obtained. 
To determine accuracy of the proposed method, three different 
levels of drug concentrations were prepared from independent stock 
solution and analyzed. Accuracy was assessed as the mean 
percentage Bias. 
Precision 
Intra-day and inter-day variation was taken to determine 
intermediate precision of the proposed method. Different levels of 
drug concentrations in triplicates were prepared three different 
times in a day and studied for intra-day variation. The same drug 
concentrations were prepared on three different days to study inter-
day variation. %Relative standard deviation (%RSD) were calculated 
which should be less than 2%. 
Limit of detection (LOD) and Limit of quantitation (LOQ) 
LOD was determined using the relation 3.3 σ/s where ‘σ’ is the 
standard deviation of the response and ‘s’ is the slope of the 
calibration curve.  
The standard deviation of the response can be obtained either by 
measuring the standard deviation of the blank response or by 
calculating the residual standard deviation of the regression line 
or by calculating the standard deviation of the y-intercept of the 
regression line, i.e. the standard error of the estimate. Similarly, 
LOQ was determined using the relation 10 σ/s. 
RESULTS 
An attempt has been made to develop a simple, sensitive, 
reproducible, fast and economic analytical method for the 
simultaneous estimation of Famotidine and Rabeprazole in bulk 
form using Simultaneous equation method. This method uses the 
absorbance at two selected wavelengths. One is the λmax of 
Famotidine and other being the λmax of Rabeprazole. From the stock 
solution, working standard solutions of Famotidine and Rabeprazole 
were prepared by appropriate dilution and were scanned in the 
entire UV range to determine the λmax
Famotidine have λ
 of both the drugs.  
max at 263 nm and Rabeprazole at λmax
 
 284 nm. A 
series of standard solutions were prepared for both Famotidine and 
Rabeprazole and absorbances of solutions were recorded at 263 nm 
and 284 nm to plot a calibration curve of absorbance versus 
concentration. Regression equation and Absorptivity values of 
Famotidine and Rabeprazole were determined at selected 
wavelengths are presented in table 1. 
 
 
Fig. 3: Spectrum of Famotidine 
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Fig. 4: Spectrum of Rabeprazole 
 
Table 1: Result of analytical method development in SGF pH 1.2 
Parameter Famotidine Rabeprazole 
At 263 nm At 284 nm At 263 nm At 284 nm 
Absorptivity 330.75 200.73 366.505 346.55 
Regression equation Slope 0.0299 0.0161 0.0345 0.0343 
Intercept 0.0276 0.0356 0.0171 0.0038 
Correlation coefficient (r2 0.9968 ) 0.9865 0.9979 0.9998 
 
The concentration of two drugs in the mixture was calculated by 
using the equation (1) and (2). The percentage purity of Famotidine 
and Rabeprazole in Laboratory mixture is shown in the table 2. 
Using the %RSD of the absorbance of six replicate injections of the 
drug, the precision of the spectrophotometer system was 
determined.
  
Table 2: Determination of Famotidine and Rabeprazole in Laboratory mixture 
Mixture content Label content (µg) Amount found (µg) %Amount* ±SD* 
Famotidine 10 9.96 99.60 ±0.050 
Rabeprazole 10 9.84 98.40 ±0.032 
*Mean of six readings 
 
Inorder to prove the validity and applicability of the proposed 
method, studies were carried out as per ICH Guidelines and their 
results are presented in table 3. LOD and LOQ values for Famotidine 
and Rabeprazole are stated in table 3. 
 
Table 3: Validation ofthe proposed method 
Parameter Famotidine at 263 nm Famotidine at 284 nm Rabeprazole at 263 nm Rabeprazole at 284 nm 
Beer’s Law Limit (µg/ml) 5-30 5-30 5-30 5-30 
LOD (µg/ml) 1.927 1.55 0.3535 0.3807 
LOQ (µg/ml) 5.839 4.72 1.0719 1.1535 
Precision 
(%RSD) 
Interday 0.14-0.29 0.07-0.34 0.25-0.59 0.2-0.71 
Intraday 0.16-0.33 0.23-0.38 0.18-0.21 0.1-0.27 
Accuracy (% Bias) 0.02-0.15 0.1-0.14 0.07-0.11 0.08-0.19 
 
DISCUSSION 
UV Spectrophotometric method was successfully developed and 
validated for the combination of Famotidine and rabeprazole. 
The calibration curves were found to be linear in the 
concentration range under study. The Correlation coefficient of 
these drugs was found to be close to 1.00, indicating good 
linearity the % RSD in both intraday and interday precision 
study was found to be less than 2 which indicates the precision 
of the method. Satisfactory results were obtained with %RSD 
value less than 2 %; thus confirming the accuracy and precision 
of the proposed method. 
CONCLUSION 
The proposed method was proved to be simple, accurate, precise, 
sensitive, rapid, reproducible and economical for the simultaneous 
estimation of Famotidine and Rabeprazole sodium in combined 
Laboratory mixture. The % RSD. values were found to be less than 
2% as required by ICH guidelines, which indicates the accuracy of 
methods; thus this method can be used for routine simultaneous 
determination of Famotidine and Rabeprazole in bulk drug and can 
be used to carry out the simultaneous estimation in the dosage form. 
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